{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:16:20Z","timestamp":1783048580353,"version":"3.54.6"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013225","name":"Academy of Scientific and Innovative Research","doi-asserted-by":"publisher","award":["10BB23J71007"],"award-info":[{"award-number":["10BB23J71007"]}],"id":[{"id":"10.13039\/501100013225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["DST\/SUPREME\/2023\/70"],"award-info":[{"award-number":["DST\/SUPREME\/2023\/70"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bpc.2026.107641","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:17:43Z","timestamp":1777519063000},"page":"107641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serum metabolomic profiling by 1H NMR reveals distinct metabolic signatures in diabetic and non-diabetic chronic kidney disease"],"prefix":"10.1016","volume":"335","author":[{"given":"Amrita","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasna","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Baishya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupma","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2026.107641_bb0005","author":"Landray"},{"key":"10.1016\/j.bpc.2026.107641_bb0010","series-title":"Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, And hospitalization","author":"Go","year":"2004"},{"key":"10.1016\/j.bpc.2026.107641_bb0015","author":"Jha"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2015.02.338","article-title":"A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury","volume":"66","author":"James","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.bpc.2026.107641_bb0025","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/j.ajkd.2023.10.010","article-title":"Variations in incidence and prognosis of stage 4 CKD among adults identified using different algorithms: a population-based cohort study","volume":"83","author":"Rath","year":"2024","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.bpc.2026.107641_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M21-2928","article-title":"Prediction of end-stage kidney Disease using estimated glomerular filtration rate with and without race a prospective cohort study","volume":"175","author":"Bundy","year":"2022","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0035","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.ajkd.2023.03.014","article-title":"Utility of the kidney failure risk equation and estimated GFR for estimating time to kidney failure in advanced CKD","volume":"82","author":"Chu","year":"2023","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bpc.2026.107641_bb0040","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.bpc.2026.107641_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5694\/j.1326-5377.2006.tb00499.x","article-title":"The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)","volume":"185","author":"Thomas","year":"2006","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000506634","article-title":"Diabetic kidney disease: challenges, advances, and opportunities","volume":"6","author":"Chen","year":"2020","journal-title":"Kidney Dis."},{"key":"10.1016\/j.bpc.2026.107641_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2024.100313","article-title":"The role of kidney biopsy in deciphering diabetic versus non-diabetic origin of kidney disease among patients with type 2 diabetes mellitus and nephrotic range proteinuria: a retrospective study","volume":"23","author":"Kardalas","year":"2024","journal-title":"Metab. Open"},{"key":"10.1016\/j.bpc.2026.107641_bb0070","author":"Fox"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/diabetology5040030","article-title":"Proteinuric and non-proteinuric diabetic kidney disease: different presentations of the same disease?","volume":"5","author":"Fabre","year":"2024","journal-title":"Diabetology"},{"key":"10.1016\/j.bpc.2026.107641_bb0080","author":"Villar"},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0085","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/0886022X.2022.2106872","article-title":"Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study","volume":"44","author":"Chen","year":"2022","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0090","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s11606-013-2595-x","article-title":"Pitfalls in hemoglobin A1c measurement: when results may be misleading","volume":"29","author":"Radin","year":"2013","journal-title":"J. Gen. Intern. Med."},{"issue":"5","key":"10.1016\/j.bpc.2026.107641_bb0095","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Disease","year":"2022","journal-title":"Kidney. Int."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13098-025-01780-y","article-title":"Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry","volume":"17","author":"Zhang","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-79611-9","article-title":"A sustainable HPTLC approach for green assessment of tyrosine to phenylalanine ratio in chronic kidney disease","volume":"14","author":"Kamel","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107641_bb0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-030-51652-9_2","article-title":"NMR-based metabolomics","volume":"1280","author":"Nagana Gowda","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.bpc.2026.107641_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00125-024-06108-5","article-title":"Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank","volume":"67","author":"Jin","year":"2024","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0120","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.ajkd.2020.01.019","article-title":"Metabolomic markers of kidney function decline in patients with diabetes: evidence from the chronic renal insufficiency cohort (CRIC) study","volume":"76","author":"Kwan","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bpc.2026.107641_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114885","article-title":"Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes","volume":"219","author":"Lucio-Guti\u00e9rrez","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bpc.2026.107641_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116240","article-title":"Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus","volume":"247","author":"Lucio-Guti\u00e9rrez","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bpc.2026.107641_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100354","article-title":"Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease","volume":"25","author":"Guo","year":"2025","journal-title":"Metabol Open."},{"issue":"10","key":"10.1016\/j.bpc.2026.107641_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bpc.2026.107641_bb0145","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2016.05.018","article-title":"Changes in serum metabolites with the stage of chronic kidney disease: comparison of diabetes and non-diabetes","volume":"459","author":"Lee","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0150","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."},{"issue":"Supplement_1","key":"10.1016\/j.bpc.2026.107641_bb0155","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. diagnosis and classification of diabetes: standards of care in diabetes\u20142025","volume":"48","author":"Committee ADAPP","year":"2025","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.bpc.2026.107641_bb0160","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ajhp\/zxaf044","article-title":"KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: a primer on what pharmacists need to know","volume":"82","author":"Awdishu","year":"2025","journal-title":"Am. J. Health-Syst. Pharm."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD","volume":"85","author":"Navaneethan","year":"2025","journal-title":"Am. J. Kidney Dis."},{"issue":"7\u20138","key":"10.1016\/j.bpc.2026.107641_bb0170","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cca.2010.01.016","article-title":"Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis","volume":"411","author":"Kumar","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.lungcan.2011.02.008","article-title":"A metabolomic approach to lung cancer","volume":"74","author":"Hori","year":"2011","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0320","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cmet.2017.07.006","article-title":"Plasma mannose levels are associated with incident type 2 diabetes and cardiovascular disease","volume":"26","author":"Mardinoglu","year":"2017","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.bpc.2026.107641_bb0180","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1021\/acs.analchem.0c04952","article-title":"Diffusion and relaxation edited proton NMR spectroscopy of plasma reveals a high-fidelity supramolecular biomarker signature of SARS-CoV-2 infection","volume":"93","author":"Holmes","year":"2021","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0185","doi-asserted-by":"crossref","first-page":"11729","DOI":"10.1038\/s41598-023-38703-8","article-title":"Plasma lipid metabolites as potential biomarkers for identifying individuals at risk of obesity-induced metabolic complications","volume":"13","author":"Bellot","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15346-0","article-title":"Potential application of 1H NMR for routine serum lipidome analysis -evaluation of effects of bariatric surgery","volume":"7","author":"Mika","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0195","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/bip.10299","article-title":"1H-NMR and 13C-NMR lipid profiles of human renal tissues","volume":"72","author":"Tugnoli","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.bpc.2026.107641_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.plipres.2017.09.003","article-title":"Applications of nuclear magnetic resonance in lipid analyses: an emerging powerful tool for lipidomics studies","volume":"68","author":"Li","year":"2017","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.bpc.2026.107641_bb0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/metabo8030047","article-title":"Statistical analysis of NMR metabolic fingerprints: established methods and recent advances","volume":"8","author":"Zacharias","year":"2018","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.bpc.2026.107641_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/00365513.2014.1003593","article-title":"Preprocessing of NMR metabolomics data","volume":"75","author":"Euceda","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bpc.2026.107641_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-0716-0239-3_5","article-title":"Analysis of NMR metabolomics data","volume":"2104","author":"Pathmasiri","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0220","first-page":"627","article-title":"Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation","volume":"4","author":"Hajian-Tilaki","year":"2013","journal-title":"Caspian J. Intern. Med."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.bpc.2026.107641_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/mrc.70019","article-title":"Metabolic reprogramming in pheochromocytoma and paraganglioma: insights from untargeted NMR metabolomics presurgical and postsurgical intervention","author":"Kaur","year":"2025","journal-title":"Magn. Reson. Chem."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0235","doi-asserted-by":"crossref","first-page":"30676","DOI":"10.1038\/s41598-025-16493-5","article-title":"NMR based clinical metabolomics revealed altered lipid and sugar metabolism in systemic sclerosis with implications for diagnosis and therapeutic strategies","volume":"15","author":"Singh","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107641_bb0240","series-title":"MSEA: A Web-Based Tool to Identify Biologically Meaningful Patterns in Quantitative Metabolomic Data [Internet]","author":"Xia","year":"2026"},{"issue":"9","key":"10.1016\/j.bpc.2026.107641_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009105","article-title":"Pathway analysis in metabolomics: recommendations for the use of over-representation analysis","volume":"17","author":"Wieder","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"D1","key":"10.1016\/j.bpc.2026.107641_bb0250","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkae909","article-title":"KEGG: biological systems database as a model of the real world","volume":"53","author":"Kanehisa","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.bpc.2026.107641_bb0255","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc08-0779","article-title":"Anemia, diabetes, and chronic kidney disease","volume":"32","author":"Mehdi","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ndt\/gfi163","article-title":"The unrecognized prevalence of chronic kidney disease in diabetes","volume":"21","author":"Middleton","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ackd.2017.10.011","article-title":"The global epidemiology of diabetes and kidney disease","volume":"25","author":"Koye","year":"2018","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"11","key":"10.1016\/j.bpc.2026.107641_bb0270","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1039\/C7MB00167C","article-title":"Metabolomics reveal mitochondrial and fatty acid metabolism disorders that contribute to the development of DKD in T2DM patients","volume":"13","author":"Li","year":"2017","journal-title":"Mol. Biosyst."},{"issue":"6","key":"10.1016\/j.bpc.2026.107641_bb0275","doi-asserted-by":"crossref","first-page":"R1478","DOI":"10.1152\/ajpregu.00386.2004","article-title":"L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla","volume":"287","author":"Kakoki","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bpc.2026.107641_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.682482","article-title":"Trimethylamine N-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0285","first-page":"85","article-title":"Trimethylamine N-oxide and kidney diseases: what do we know?","volume":"46","author":"Gungor","year":"2023","journal-title":"J. Bras. Nefrol."},{"key":"10.1016\/j.bpc.2026.107641_bb0290","first-page":"234","article-title":"Development of a novel method for the simultaneous detection of trimethylamine N-oxide and creatinine in the saliva of patients with chronic kidney disease \u2013 its utility in saliva as an alternative to blood","author":"Korytowska-Przybylska","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bpc.2026.107641_bb0295","series-title":"Increased Urinary Osmolyte Excretion Indicates Chronic Kidney Disease Severity And Progression Rate","author":"Gil","year":"2018"},{"issue":"12","key":"10.1016\/j.bpc.2026.107641_bb0300","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s41581-024-00872-8","article-title":"Amino acid metabolism in kidney health and disease","volume":"20","author":"Knol","year":"2024","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bpc.2026.107641_bb0305","first-page":"170","article-title":"Glycine as a conditionally essential amino acid and its relationship to l-serine","author":"Hole\u010dek","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/j.bpc.2026.107641_bb0310","first-page":"341","article-title":"Impacts of glutamate, an exercise-responsive metabolite on insulin signaling","author":"Xing","year":"2024","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bpc.2026.107641_bb0315","doi-asserted-by":"crossref","DOI":"10.1093\/jn\/137.6.1586S","article-title":"Phenylalanine and tyrosine metabolism in chronic kidney failure","volume":"137","author":"Kopple","year":"2007","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10408363.2017.1414143","article-title":"Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes","volume":"55","author":"Gar","year":"2018","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"8","key":"10.1016\/j.bpc.2026.107641_bb0330","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/00365519950185094","article-title":"Metabolic syndrome is associated with changes in D-mannose metabolism","volume":"59","author":"Pitk\u00e4nen","year":"1999","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"5","key":"10.1016\/j.bpc.2026.107641_bb0335","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41575-023-00888-8","article-title":"Hepatic glucose metabolism in the steatotic liver","volume":"21","author":"Scoditti","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.bpc.2026.107641_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091259","article-title":"Involvement of tricarboxylic acid cycle metabolites in kidney diseases","volume":"11","author":"Jim\u00e9nez-uribe","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bpc.2026.107641_bb0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2017.10.027","article-title":"Metabolomics and gene expression analysis reveal down-regulation of the citric acid (TCA) cycle in non-diabetic CKD patients","volume":"26","author":"Hallan","year":"2017","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.bpc.2026.107641_bb0350","doi-asserted-by":"crossref","DOI":"10.34067\/KID.0000000000000153","article-title":"Energy metabolism dysregulation in chronic kidney disease","volume":"4","author":"Li","year":"2023","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0355","article-title":"Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review","volume":"69","author":"Cavalcanti Sette","year":"2014","journal-title":"Clinics"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0360","first-page":"377","article-title":"Glucose and insulin metabolism in uremia","volume":"61","author":"Mak","year":"1992","journal-title":"Nephron"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0365","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1681\/ASN.2021050680","article-title":"Decreased renal gluconeogenesis is a hallmark of chronic kidney disease","volume":"33","author":"Verissimo","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bpc.2026.107641_bb0370","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxlet.2016.12.017","article-title":"Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria","volume":"267","author":"Makrecka-Kuka","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0375","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2005.06.006","article-title":"Disorders of pyruvate metabolism and the tricarboxylic acid cycle","volume":"85","author":"Pithukpakorn","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bpc.2026.107641_bb0380","article-title":"Glycerol and Glycerol-3-phosphate: multifaceted metabolites in metabolism, cancer, and other diseases","author":"SRM","year":"2025","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.bpc.2026.107641_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298729","article-title":"Mannose and glycine: metabolites with potentially causal implications in chronic kidney disease pathogenesis","volume":"19","author":"Hu","year":"2024","journal-title":"PloS One"},{"key":"10.1016\/j.bpc.2026.107641_bb0390","article-title":"Characteristics of serum metabolites and gut microbiota in diabetic kidney disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0395","article-title":"Oxidation resistance of the sulfur amino acids: methionine and cysteine","volume":"2017","author":"Bin","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.bpc.2026.107641_bb0400","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2337\/dc10-1006","article-title":"Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine","volume":"34","author":"Sekhar","year":"2011","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.bpc.2026.107641_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/nu17172904","article-title":"Gut microbiome-derived short-chain fatty acids in glomerular protection and modulation of chronic kidney disease progression","volume":"17","author":"Szrejder","year":"2025","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.bpc.2026.107641_bb0410","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1590\/2175-8239-jbn-2018-0214","article-title":"Dietary intake of tyrosine and phenylalanine, and p-cresyl sulfate plasma levels in non-dialyzed patients with chronic kidney disease","volume":"42","author":"Fernandes","year":"2020","journal-title":"J. Bras. Nefrol."},{"issue":"10","key":"10.1016\/j.bpc.2026.107641_bb0415","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.7150\/ijbs.95216","article-title":"Lipid homeostasis in diabetic kidney disease","volume":"2024","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.bpc.2026.107641_bb0435","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jdiacomp.2015.06.016","article-title":"Metabolomic biomarkers in diabetic kidney diseases\u2014a systematic review","volume":"29","author":"Zhang","year":"2015","journal-title":"J. Diabetes Complications"},{"issue":"4","key":"10.1016\/j.bpc.2026.107641_bb0420","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/ajcn\/75.4.780","article-title":"Long-chain polyunsaturated fatty acids and diabetes mellitus","volume":"75","author":"Das","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.bpc.2026.107641_bb0425","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/metabo14080457","article-title":"Alterations in choline metabolism in non-obese individuals with insulin resistance and type 2 diabetes mellitus","volume":"14","author":"Al-Sulaiti","year":"2024","journal-title":"Metabolites"}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462226000748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462226000748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:29:16Z","timestamp":1783045756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462226000748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":86,"alternative-id":["S0301462226000748"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2026.107641","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum metabolomic profiling by 1H NMR reveals distinct metabolic signatures in diabetic and non-diabetic chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2026.107641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107641"}}